Y. Liaw Et Al. , "2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B," GASTROENTEROLOGY , vol.136, no.2, pp.486-495, 2009
Liaw, Y. Et Al. 2009. 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B. GASTROENTEROLOGY , vol.136, no.2 , 486-495.
Liaw, Y., Gane, E., Leung, N., Zeuzem, S., Wang, Y., Lai, C. L., ... Heathcote, E. J.(2009). 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B. GASTROENTEROLOGY , vol.136, no.2, 486-495.
Liaw, Yun-Fan Et Al. "2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B," GASTROENTEROLOGY , vol.136, no.2, 486-495, 2009
Liaw, Yun-Fan Et Al. "2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B." GASTROENTEROLOGY , vol.136, no.2, pp.486-495, 2009
Liaw, Y. Et Al. (2009) . "2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B." GASTROENTEROLOGY , vol.136, no.2, pp.486-495.
@article{article, author={Yun-Fan Liaw Et Al. }, title={2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B}, journal={GASTROENTEROLOGY}, year=2009, pages={486-495} }